Sinovac Biotech Ltd (SVA) — Net Asset Quality Index
Sinovac Biotech Ltd (SVA) has a Net Asset Quality Index of 89.2% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $12.90 Billion minus total liabilities of $1.39 Billion yields net assets of $11.51 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Sinovac Biotech Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sinovac Biotech Ltd Net Asset Quality Index Over Time (1998–2023)
This chart shows how Sinovac Biotech Ltd's Net Asset Quality Index has evolved across 25 annual periods from 1998 to 2023. As of June 2024, the index stands at 89.2%, representing net assets of $11.51 Billion against total assets of $12.90 Billion USD. Explore Sinovac Biotech Ltd cash conversion from operations to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Sinovac Biotech Ltd (1998–2023)
The table below presents the year-by-year Net Asset Quality Index for Sinovac Biotech Ltd from 1998 to 2023, covering 25 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Sinovac Biotech Ltd (SVA) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 88.0% | $12.02 Billion | $13.66 Billion | $1.64 Billion | ▼ -2.0 pp |
| 2022 | 90.1% | $12.71 Billion | $14.11 Billion | $1.40 Billion | ▲ +7.2 pp |
| 2021 | 82.9% | $13.88 Billion | $16.75 Billion | $2.87 Billion | ▲ +23.9 pp |
| 2020 | 58.9% | $1.12 Billion | $1.90 Billion | $781.20 Million | ▼ -19.0 pp |
| 2019 | 77.9% | $352.19 Million | $452.30 Million | $100.10 Million | ▼ -1.1 pp |
| 2018 | 78.9% | $291.93 Million | $369.78 Million | $77.85 Million | ▲ +17.6 pp |
| 2017 | 61.3% | $129.67 Million | $211.35 Million | $81.69 Million | ▲ +0.0 pp |
| 2016 | 61.3% | $129.67 Million | $211.35 Million | $81.69 Million | ▼ -5.9 pp |
| 2015 | 67.3% | $136.50 Million | $202.93 Million | $66.42 Million | ▲ +7.9 pp |
| 2014 | 59.4% | $141.73 Million | $238.53 Million | $96.80 Million | ▼ -0.3 pp |
| 2013 | 59.7% | $143.64 Million | $240.69 Million | $97.05 Million | ▼ -2.3 pp |
| 2012 | 62.0% | $129.44 Million | $208.76 Million | $79.33 Million | ▼ -5.3 pp |
| 2011 | 67.3% | $145.30 Million | $215.91 Million | $70.61 Million | ▼ -1.6 pp |
| 2010 | 68.9% | $147.76 Million | $214.36 Million | $66.60 Million | ▲ +10.9 pp |
| 2009 | 58.1% | $84.47 Million | $145.48 Million | $61.01 Million | ▼ -11.2 pp |
| 2008 | 69.3% | $53.64 Million | $77.44 Million | $23.80 Million | ▲ +12.0 pp |
| 2007 | 57.3% | $32.90 Million | $57.45 Million | $24.55 Million | ▼ -0.3 pp |
| 2006 | 57.6% | $21.31 Million | $37.01 Million | $15.70 Million | ▼ -13.1 pp |
| 2005 | 70.6% | $16.51 Million | $23.37 Million | $6.86 Million | ▲ +1.2 pp |
| 2004 | 69.4% | $15.56 Million | $22.42 Million | $6.86 Million | ▼ -3.7 pp |
| 2003 | 73.1% | $10.89 Million | $14.90 Million | $4.01 Million | ▲ +31.0 pp |
| 2002 | 42.1% | $99.44K | $236.25K | $136.81K | ▲ +295.8 pp |
| 2001 | -253.7% | $-682.96K | $269.19K | $952.15K | ▲ +0.0 pp |
| 2000 | -253.7% | $-682.96K | $269.19K | $952.15K | ▼ -340.3 pp |
| 1998 | 86.6% | $29.01K | $33.51K | $4.50K | — |